Výsledky vyhledávání

The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients

Autor: A E, van Ede, R F, Laan, H J, Blom, T W, Huizinga, C J, Haagsma, B A, Giesendorf, T M, de Boo, L B, van de Putte

Publikováno v: Arthritis and rheumatism. 44(11)

To study the possible relationship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and the toxicity and efficacy of treatment with methotrexate (MTX) in patients with rheumatoid arthritis (RA).Genotype analysis of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9435b8a885397452aca18771eadf3d21
https://pubmed.ncbi.nlm.nih.gov/11710708

Zobrazit plný text záznamu

Patient satisfaction after total knee arthroplasty: a comparison between subjective and objective outcome assessments

Autor: P H, Bullens, C J, van Loon, M C, de Waal Malefijt, R F, Laan, R P, Veth

Publikováno v: The Journal of arthroplasty. 16(6)

We used a visual analog scale (VAS) to assess the satisfaction after total knee arthroplasty (TKA) in a group of 108 patients (126 TKAs) with short-term to medium-term follow-up. We also used the Knee Society scoring system, Western Ontario and McMas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2919074b96d453557698b6a9d2f901e8
https://pubmed.ncbi.nlm.nih.gov/11547372

Zobrazit plný text záznamu

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

Autor: A E, van Ede, R F, Laan, M J, Rood, T W, Huizinga, M A, van de Laar, C J, van Denderen, T A, Westgeest, T C, Romme, D J, de Rooij, M J, Jacobs, T M, de Boo, G J, van der Wilt, J L, Severens, M, Hartman, P F, Krabbe, B A, Dijkmans, F C, Breedveld, L B, van de Putte

Publikováno v: Arthritis and rheumatism. 44(7)

To study the effect of folates on discontinuation of methotrexate (MTX) as single-drug antirheumatic treatment due to toxicity, to determine which type of adverse events are reduced, to study the effects on the efficacy of MTX, and to compare folic w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7fffc49fb9bffb27051c6c368e3d1c49
https://pubmed.ncbi.nlm.nih.gov/12115259

Zobrazit plný text záznamu

Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease

Autor: E J, Kroot, M G, Nieuwenhuizen, M C, de Waal Malefijt, P L, van Riel, P C, Pasker-de Jong, R F, Laan

Publikováno v: Arthritis and rheumatism. 44(6)

Rheumatoid arthritis (RA) has been reported to be associated with bone loss during the first years of the disease. The magnitude of this problem after the initial years has not yet been evaluated. In the present study, the change in bone mineral dens

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c19c5600573ef4e94667643a9333590
https://pubmed.ncbi.nlm.nih.gov/11407683

Zobrazit plný text záznamu

A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss

Autor: J D, Adachi, C, Roux, P I, Pitt, C, Cooper, C, Moniz, J, Dequeker, G, Ioannidis, M I, Cawley, E A, Jenkins, K E, Walker-Bone, S, Pack, G F, Stephenson, R F, Laan, J, Brown, P, Geusens

Publikováno v: The Journal of rheumatology. 27(10)

To conduct a pooled data analysis in a group of patients defined by sex, menopausal status, and underlying disease in order to examine the effect of intermittent cyclical etidronate in the prevention and treatment of corticosteroid induced osteoporos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9741823da418cd639947f031a558bb34
https://pubmed.ncbi.nlm.nih.gov/11036840

Zobrazit plný text záznamu

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

Autor: D M, Reid, R A, Hughes, R F, Laan, N A, Sacco-Gibson, D H, Wenderoth, S, Adami, R A, Eusebio, J P, Devogelaer

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 15(6)

Long-term use of high-dose corticosteroids often results in bone loss, which may lead to osteoporosis-related fractures. This was a multicenter, double-blind study in which 290 ambulatory men and women receiving high-dose oral corticosteroid therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17a70a719d395ee09995151db873f63c
https://pubmed.ncbi.nlm.nih.gov/10841169

Zobrazit plný text záznamu

Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: a case report and review of the literature

Autor: P A, te Boekhorst, P, Barrera, R F, Laan, L B, van de Putte

Publikováno v: Clinical and experimental rheumatology. 17(3)

We report a case of severe hepatotoxic reaction during gold therapy for rheumatoid arthritis. The previous literature on this condition is reviewed and the possible mechanisms of gold-induced hepatotoxicity are discussed.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::df87ab33b6ae793c591086979e4b36a6
https://pubmed.ncbi.nlm.nih.gov/10410273

Zobrazit plný text záznamu

Akademický článek

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.

Autor: T. P. Van Staa, R. F. Laan, I. P. Barton, S. Cohen, D. M. Reid, C. Cooper

Publikováno v: Arthritis & Rheumatism; Nov2003, Vol. 48 Issue 11, p3224-3229, 6p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání